C07F 9/00
Compounds containing elements of groups 5 or 15 of the periodic table
Official title: Compounds containing elements of Groups 5 or 15 of the Periodic Table
C07F9/00 (Compounds containing elements of groups 5 or 15 of the periodic table) appears on 18,170 US grants and 12,324 published applications in this corpus.
Search patents in C07F- Granted patents
- 18,170
- Published applications
- 12,324
- Assignees
- 4,955
- Inventors
- 33,372
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 596 | 0 |
| 1977 | 465 | 0 |
| 1978 | 619 | 0 |
| 1979 | 340 | 0 |
| 1980 | 362 | 0 |
| 1981 | 426 | 0 |
| 1982 | 267 | 0 |
| 1983 | 283 | 0 |
| 1984 | 336 | 0 |
| 1985 | 346 | 0 |
| 1986 | 266 | 0 |
| 1987 | 311 | 0 |
| 1988 | 283 | 0 |
| 1989 | 284 | 0 |
| 1990 | 287 | 0 |
| 1991 | 317 | 0 |
| 1992 | 324 | 0 |
| 1993 | 355 | 0 |
| 1994 | 327 | 0 |
| 1995 | 326 | 0 |
| 1996 | 346 | 0 |
| 1997 | 414 | 0 |
| 1998 | 444 | 0 |
| 1999 | 369 | 0 |
| 2000 | 335 | 0 |
| 2001 | 344 | 80 |
| 2002 | 360 | 346 |
| 2003 | 348 | 393 |
| 2004 | 270 | 469 |
| 2005 | 219 | 454 |
| 2006 | 289 | 448 |
| 2007 | 248 | 401 |
| 2008 | 268 | 404 |
| 2009 | 281 | 462 |
| 2010 | 326 | 482 |
| 2011 | 305 | 481 |
| 2012 | 360 | 449 |
| 2013 | 403 | 495 |
| 2014 | 432 | 578 |
| 2015 | 500 | 563 |
| 2016 | 441 | 574 |
| 2017 | 440 | 544 |
| 2018 | 458 | 588 |
| 2019 | 495 | 556 |
| 2020 | 436 | 488 |
| 2021 | 375 | 501 |
| 2022 | 321 | 535 |
| 2023 | 325 | 576 |
| 2024 | 329 | 555 |
| 2025 | 346 | 512 |
| 2026 | 223 | 390 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin6 Oct 2026US 12,751,960 B2Compass Pathfinder Limited
- PHD inhibitor compounds, compositions, and use6 Oct 2026US 12,753,161 B2Akebia Therapeutics, Inc.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Biosynthesis of chemically diversified non-natural terpene products6 Oct 2026US 12,753,423 B2Board of Trustees of Michigan State University
- Polyhydroxylated cyclopentane derivatives and methods of use29 Sep 2026US 12,747,257 B2Sanegene Bio USA Inc.
- Novel phosphoantigen prodrug compound and use thereof8 Oct 2026US 2026/0306541 A1
- Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents8 Oct 2026US 2026/0306634 A1Wisconsin Alumni Research Foundation
- Substituted pyrimidinedione compounds, compositions, and uses thereof8 Oct 2026US 2026/0308184 A1Lakewood Amedex, Inc.
- Stat degraders and uses thereof8 Oct 2026US 2026/0308185 A1Recludix Pharma, Inc.
- Stat degraders and uses thereof8 Oct 2026US 2026/0308186 A1Recludix Pharma, Inc.
Most cited
By later US patents
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991
- Polymeric transition metal complexes and uses thereof1,155US 6,605,200 B1TheraSense, Inc. · 2003
- Transition metal complexes with bidentate ligand having an imidazole ring and sensor constructed therewith1,152US 6,605,201 B1TheraSense, Inc. · 2003
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Synthetic phosphatidyl cholines useful in forming liposomes664US 4,485,045 AResearch Corporation · 1984